Interviews
We interview Dr. Paul Thielking, Chief Science Officer of Numinus, about the use of psychedelics in palliative care and end...
This week on the Psychedelic Spotlight podcast, we provide a recap of the inaugural Benzinga Psychedelic Capital Conference which took...
CEO of Mindset Pharma, James Lanthier, gives us an overview of his company and the 4 new psychedelics they are...
Co-Founder and CEO, Matt Stang, gives us an overview of the company's clinics, Delic Labs and more....
In this chat, he discusses some of the challenges involved in moving virtual events to an in-person conference (during a...
In our conversation, James goes into detail about Mindset’s new lead drug candidate MSP-1014, when the company expects to take...
In this wide ranging interview many topics are covered, starting with the philosophy and vision of Bright Minds. We discuss...
In our conversation with Trevor, we have the opportunity to discuss some of the psychedelic-based treatments NeonMind is currently focused...